Search Results
You are looking at 1 - 2 of 2 items for
- Author: Maristela Okamoto x
- Refine by access: All content x
Search for other papers by Julie Takada in
Google Scholar
PubMed
Search for other papers by Miriam Helena Fonseca-Alaniz in
Google Scholar
PubMed
Search for other papers by Tarcila Beatriz Ferraz de Campos in
Google Scholar
PubMed
Search for other papers by Sandra Andreotti in
Google Scholar
PubMed
Search for other papers by Amanda Baron Campana in
Google Scholar
PubMed
Search for other papers by Maristela Okamoto in
Google Scholar
PubMed
Search for other papers by Cristina das Neves Borges-Silva in
Google Scholar
PubMed
Search for other papers by Ubiratan Fabres Machado in
Google Scholar
PubMed
Search for other papers by Fabio Bessa Lima in
Google Scholar
PubMed
Obesity and insulin resistance are highly correlated with metabolic disturbances. Both the excess and lack of adipose tissue can lead to severe insulin resistance and diabetes. Adipose tissue plays an active role in energy homeostasis, hormone secretion, and other proteins that affect insulin sensitivity, appetite, energy balance, and lipid metabolism. Rats with streptozotocin-induced diabetes during the neonatal period develop the classic diabetic picture of hyperglycemia, hypoinsulinemia, and insulin resistance in adulthood. Low body weight and reduced epididymal (EP) fat mass were also seen in this model. The aim of this study was to investigate the glucose homeostasis and metabolic repercussions on the adipose tissue following chronic treatment with antidiabetic drugs in these animals. In the 4th week post birth, diabetic animals started an 8-week treatment with pioglitazone, metformin, or insulin. Animals were then killed, EP fat pads were excised, and blood samples were collected for biological and biochemical assays. Pioglitazone and insulin treatments, but not metformin, reduced hyperglycemia, polydipsia, and polyphagia. Although all antidiabetic therapies improved insulin sensitivity, this was particularly noteworthy in the pioglitazone-treated rats. Furthermore, a recovery of adipose mass and insulin levels were observed in pioglitazone- and insulin-, but not metformin-treated animals. Treatments with insulin or pioglitazone were able to correct significantly, but not completely, the metabolic abnormalities, parallel to full recovery of adipose mass, indicating that not only the low insulin levels but also the lack of adipose tissue might play a significant role on the pathophysiology of this particular diabetes model.
Search for other papers by Maristela Mitiko Okamoto in
Google Scholar
PubMed
Search for other papers by Gabriel Forato Anhê in
Google Scholar
PubMed
Search for other papers by Robinson Sabino-Silva in
Google Scholar
PubMed
Search for other papers by Milano Felipe dos Santos Ferreira Marques in
Google Scholar
PubMed
Search for other papers by Helayne Soares Freitas in
Google Scholar
PubMed
Search for other papers by Rosana Cristina Tieko Mori in
Google Scholar
PubMed
Search for other papers by Karla Fabiana S Melo in
Google Scholar
PubMed
Search for other papers by Ubiratan Fabres Machado in
Google Scholar
PubMed
Insulin replacement is the only effective therapy to manage hyperglycemia in type 1 diabetes mellitus (T1DM). Nevertheless, intensive insulin therapy has inadvertently led to insulin resistance. This study investigates mechanisms involved in the insulin resistance induced by hyperinsulinization. Wistar rats were rendered diabetic by alloxan injection, and 2 weeks later received saline or different doses of neutral protamine Hagedorn insulin (1.5, 3, 6, and 9 U/day) over 7 days. Insulinopenic-untreated rats and 6U- and 9U-treated rats developed insulin resistance, whereas 3U-treated rats revealed the highest grade of insulin sensitivity, but did not achieve good glycemic control as 6U- and 9U-treated rats did. This insulin sensitivity profile was in agreement with glucose transporter 4 expression and translocation in skeletal muscle, and insulin signaling, phosphoenolpyruvate carboxykinase/glucose-6-phosphatase expression and glycogen storage in the liver. Under the expectation that insulin resistance develops in hyperinsulinized diabetic patients, we believe insulin sensitizer approaches should be considered in treating T1DM.
